Log in to save to my catalogue

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_60593563f864496784633e4a8e879a02

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer

About this item

Full title

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2025-04, Vol.25 (1), p.685-12, Article 685

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The clinical characteristics of immune checkpoint inhibitors (ICIs)-related myocarditis in lung cancer remains uncertain. The purpose of this study was to evaluate the incidence, clinical characteristics, risk factors, and prognosis of myocarditis in lung cancer patients treated with ICIs. Therefore, this study would enhance the understanding of im...

Alternative Titles

Full title

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_60593563f864496784633e4a8e879a02

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_60593563f864496784633e4a8e879a02

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-025-13997-1

How to access this item